Aurora Cannabis Inc. (ACB.TO)
| Previous Close | 9.04 |
| Open | 9.08 |
| Bid | 8.88 x 0 |
| Ask | 8.90 x 0 |
| Day's Range | 8.73 - 9.08 |
| 52 Week Range | 4.93 - 24.10 |
| Volume | 636,280 |
| Avg. Volume | 1,561,911 |
| Market Cap | 1.76B |
| Beta (5Y Monthly) | 3.12 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -16.45 |
| Earnings Date | Sep. 20, 2021 - Sep. 24, 2021 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 8.39 |
- Motley Fool
Better Pot Stock: Canopy Growth vs. Aurora Cannabis
This year has already brought us some big acquisitions, both in Canada and in the U.S. Perhaps the biggest was the merging of two Canadian players, Aphria and Tilray, to create the "new" Tilray, which was completed in May. The recent acquisition of Harvest Health & Recreation by Florida-based Trulieve Cannabis was also a highlight. Canadian player Aurora Cannabis (NASDAQ: ACB) has been on a roller-coaster ride since 2020, while fellow Canadian company Canopy Growth (NASDAQ: CGC) has held its ground. Let's take a look at their progress this year and determine which of these two pot stocks is the better buy now.
- Yahoo Finance
Marijuana reform: Sen. Cory Booker clarifies stance on key banking bill
Sen. Cory Booker clarified his support for marijuana banking reform in a new Yahoo Finance interview.
- Yahoo Finance Video
Sen. Cory Booker on legalizing marijuana: ‘We’re on the right side of history in America’
Senator Cory Booker of New Jersey, joins Yahoo Finance to discuss legalizing marijuana, injustices in the U.S. system regarding marijuana usage, and the bipartisan infrastructure deal.
